BALYASNY ASSET MANAGEMENT LLC 13D and 13G filings for Dicerna Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 06:11 am Sale | 2021-12-31 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | BALYASNY ASSET MANAGEMENT LLC | 0 0.000% | -4,408,952 (Position Closed) | Filing |
| 2021-12-03 06:09 am Purchase | 2021-11-23 | 13G | Dicerna Pharmaceuticals, Inc. DRNA | BALYASNY ASSET MANAGEMENT LLC | 4,408,952 5.670% | 4,408,952 (New Position) | Filing |